Literature DB >> 15804709

Anti-ribosomal P protein antibodies.

Roberto Gerli1, Laura Caponi.   

Abstract

Anti-ribosomal P protein antibodies (Abs) recognize three specific ribosomal proteins located in the large ribosome's subunit. The term anti-ribosomal P protein Abs, often shortened in anti-P Abs, is due to the fact that these three proteins, P0, P1 and P2, of 38, 19 and 17 Kd molecular weight, respectively, are phosphorylated. One of the major points of interest of these autoAbs derives from their high specificity for systemic lupus erythematosus (SLE), their description in other connective tissue diseases (CTDs) being only occasional. In SLE patients, their association with renal and hepatic involvement has been proposed, while the possible association with psychiatric and/or neurological involvement is still a matter of debate. From a serological point of view, a preferential association of anti-P with anti-Sm and/or anti-DNA Abs, possibly due, at least in part, to cross-reactivity, has been suggested. This observation is intriguing since all these autoAbs are considered specific serological indicators of SLE. This review will summarize clinical and serological data on anti-P Abs provided by the main studies published in the last few years and the more recent findings about proteins constituting their targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804709     DOI: 10.1080/08916930400022699

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  13 in total

1.  Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides.

Authors:  Latisha D Heinlen; Lauren L Ritterhouse; Micah T McClain; Michael P Keith; Barbara R Neas; John B Harley; Judith A James
Journal:  J Mol Med (Berl)       Date:  2010-04-17       Impact factor: 4.599

2.  International multicenter evaluation of autoantibodies to ribosomal P proteins.

Authors:  Michael Mahler; Kai Kessenbrock; Magdalena Szmyrka; Yoshinari Takasaki; Ignacio Garcia-De La Torre; Yehuda Shoenfeld; Falk Hiepe; Chen Shun-le; Carlos A von Mühlen; Henning Locht; Peter Höpfl; Allan Wiik; Westley Reeves; Marvin J Fritzler
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope.

Authors:  M Mahler; N Agmon-Levin; M van Liempt; Y Shoenfeld; A Waka; F Hiepe; A Swart; I Gürtler; M J Fritzler
Journal:  Rheumatol Int       Date:  2010-12-08       Impact factor: 2.631

4.  Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens.

Authors:  Chao Jiang; Umesh S Deshmukh; Felicia Gaskin; Harini Bagavant; Julie Hanson; Chella S David; Shu Man Fu
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

5.  Antibodies directed against ribosomal P proteins cross-react with phospholipids.

Authors:  L Caponi; C Anzilotti; G Longombardo; P Migliorini
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

6.  The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas.

Authors:  Gehan Ahmed Mostafa; Geir Bjørklund; Mauricio A Urbina; Laila Yousef Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2016-06-01       Impact factor: 3.584

Review 7.  The role of B cells and autoantibodies in neuropsychiatric lupus.

Authors:  Jing Wen; Ariel D Stock; Samantha A Chalmers; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2016-07-05       Impact factor: 9.754

8.  The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-12-21       Impact factor: 8.322

9.  Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies.

Authors:  Michael Mahler; Jennifer T Ngo; Johannes Schulte-Pelkum; Tanja Luettich; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2008-11-11       Impact factor: 5.156

Review 10.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.